Welcome to Zarqa Genomics Lab (ZGL), your trusted ally in unraveling the mysteries encoded within your patients’ DNA. As a premier genomics laboratory, we specialize in the sequencing and interpretation of genomic data to provide unprecedented medical insights.
At ZGL, our primary focus is on conducting comprehensive whole exome and whole genome tests, delivering intricate details about genetic variants that exert influence over your patients’ health. Through the application of cutting-edge technology and expert analysis, we shed light on the complex pathways of genetic makeup, equipping you with the knowledge needed to make informed decisions for your patients’ well-being.
Stands as an advanced genetic analysis technique gaining recognition as the preferred first-line genetic test in routine clinical settings. It transcends the limitations of targeted tests by encompassing coding and non-coding regions, along with mitochondrial DNA (mtDNA), thus offering a holistic view of your patients’ genetic landscape and optimizing diagnostic value.
Presents a comprehensive approach, meticulously sequencing the exons of all protein-coding genes alongside thousands of known disease-causing variants and the mitochondrial genome. With WES, potential disease-causing variants overlooked by previous tests can be identified. Despite representing only 1-2% of the human genome, the exome harbors approximately 85% of known disease-related variants.
Patients with complex symptoms suggesting multiple underlying conditions
Mutations in the COL7A1 gene coding for type VII collagen, essential for skin integrity.
Variations in the FLG gene encoding filaggrin, a protein crucial for skin barrier function.
Mutations in the TGM1 gene responsible for encoding transglutaminase 1, critical for skin cornification.
ATP2C1 gene mutations leading to dysfunctional calcium pumps, resulting in skin blistering and erosion.
TP53 gene mutations, disrupting tumor suppressor function and predisposing individuals to skin cancer development.
Mutations in the TSC1 and TSC2 genes, leading to the formation of benign tumors in various organs, including the skin.
Sample types: saliva, blood, DBS cards, isolated DNA
TAT: All samples are processed within 30 working days
Zarqa Genomics is committed to empowering healthcare professionals like you with invaluable genetic insights to enhance patient care and improve health outcomes. Partner with us on the journey to personalized medicine and transformative healthcare solutions.
Discover our advanced genomic testing services tailored for your specific needs. Contact us today to enhance your research with unparalleled accuracy and expertise.
Get The Latest Updates via email. Any time you may unsubscribe
Copyright © 2024 Zarqa Genomics Lab, All rights reserved